Abstract
Aurora B is a serine-threonine kinase belonging to the highly conserved Aurora family of mitotic kinases. Aurora B is a chromosomal passenger protein involved in chromosome segregation, spindle-checkpoint, and cytokinesis. Alteration of each of these steps could induce aneuploidy, one of main features, and driving force of cancer progression. The overexpression of Aurora B has been observed in several tumor types, and has been linked with a poor prognosis of cancer patients. In this review we will focus on the role of Aurora B in cancer development, its role as a prognostic marker, and the clinical outcome of recently developed Aurora(s) inhibitors.
Keywords: Aurora kinase, Aurora B, serine-threonine kinase, mitosis, cytokinesis, cancer, inhibitors, Prognostic Marker, Therapeutic Target, aneuploidy, centrosome, chromosome, Testis Zinc Finger Protein (Tzfp), anaphase-promoting complex, phosphorylation, Cromosomal Passenger Complex, kinetochores, prometaphase, Survivin, INner CENtromere Pro-tein (INCENP), Histone Kinase, Tetrahymena thermophila, S. pombe, Saccharomyces cerevisiae, Drosophila, C. elegans, Xenopus, Spindle Checkpoint Kinase, microtubule-depolymerizing kinesin MCAK, Mi-totic Centromere-Associated Kinesin, Benzimidazoles, Cytokinesis Kinase, carcinoma, mesothelioma, glioblastoma, oral cancer, malignant en-dometrium, hepatocellular carcinoma, testicular germ, thyroid, colon, prostate, neoplastic lesions, Aurora Inhibitors, HESPERADIN, indolinone, chronic mye-loid leukemia (CML), acute lymphocytic leukemia
Current Medicinal Chemistry
Title: Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer
Volume: 18 Issue: 4
Author(s): G. Portella, C. Passaro and P. Chieffi
Affiliation:
Keywords: Aurora kinase, Aurora B, serine-threonine kinase, mitosis, cytokinesis, cancer, inhibitors, Prognostic Marker, Therapeutic Target, aneuploidy, centrosome, chromosome, Testis Zinc Finger Protein (Tzfp), anaphase-promoting complex, phosphorylation, Cromosomal Passenger Complex, kinetochores, prometaphase, Survivin, INner CENtromere Pro-tein (INCENP), Histone Kinase, Tetrahymena thermophila, S. pombe, Saccharomyces cerevisiae, Drosophila, C. elegans, Xenopus, Spindle Checkpoint Kinase, microtubule-depolymerizing kinesin MCAK, Mi-totic Centromere-Associated Kinesin, Benzimidazoles, Cytokinesis Kinase, carcinoma, mesothelioma, glioblastoma, oral cancer, malignant en-dometrium, hepatocellular carcinoma, testicular germ, thyroid, colon, prostate, neoplastic lesions, Aurora Inhibitors, HESPERADIN, indolinone, chronic mye-loid leukemia (CML), acute lymphocytic leukemia
Abstract: Aurora B is a serine-threonine kinase belonging to the highly conserved Aurora family of mitotic kinases. Aurora B is a chromosomal passenger protein involved in chromosome segregation, spindle-checkpoint, and cytokinesis. Alteration of each of these steps could induce aneuploidy, one of main features, and driving force of cancer progression. The overexpression of Aurora B has been observed in several tumor types, and has been linked with a poor prognosis of cancer patients. In this review we will focus on the role of Aurora B in cancer development, its role as a prognostic marker, and the clinical outcome of recently developed Aurora(s) inhibitors.
Export Options
About this article
Cite this article as:
Portella G., Passaro C. and Chieffi P., Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer, Current Medicinal Chemistry 2011; 18(4) . https://dx.doi.org/10.2174/092986711794480203
DOI https://dx.doi.org/10.2174/092986711794480203 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Use of Complementary Medicine Amongst Patients on Antiretroviral Drugs in an HIV Treatment Centre in Lagos, Nigeria
Current Drug Safety B7-H3-targeted Radioimmunotherapy of Human Cancer
Current Medicinal Chemistry Resistance to Anti-VEGF Agents
Current Pharmaceutical Design The Role of Tregs in Cancer: Foxp3 as a Putative Target for Therapy
Current Signal Transduction Therapy Alkylating Agents, the Road Less Traversed, Changing Anticancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Pathways Related to the Anti-Cancer Effects of Metabolites Derived from Cerrado Biome Native Plants: An Update and Bioinformatics Analysis on Oral Squamous Cell Carcinoma
Protein & Peptide Letters The Role of the Tyrosine Kinase Inhibitor STI571 in the Treatment of Cancer
Current Cancer Drug Targets Novel Agents Aiming at Specific Molecular Targets Increase Chemosensitivity and Overcome Chemoresistance in Hematopoietic Malignancies
Current Pharmaceutical Design Recent Patents Concerning Diagnostic and Therapeutic Applications of Aberrantly Methylated Sequences in Pancreatic Cancer
Recent Patents on DNA & Gene Sequences Intriguing Classes of Acridine Derivatives as DNA-binding Antitumour Agents: From Pyrimido[5,6,1-de]acridines to Bis(acridine-4-carboxamides)
Medicinal Chemistry Reviews - Online (Discontinued) Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology
Recent Patents on Anti-Cancer Drug Discovery Meet Our Editorial Board Member
Current Cancer Drug Targets Pharmacogenetics of Oxazaphosphorines and its Clinical Implications
Current Pharmacogenomics Airway Smooth Muscle Responsiveness: The Origin of Airway Hyperresponsiveness in Asthma?
Current Respiratory Medicine Reviews Whole Cell Biocatalysts for the Preparation of Nucleosides and their Derivatives
Current Pharmaceutical Design Antimicrobial Activity of Phenolics and Glucosinolate Hydrolysis Products and their Synergy with Streptomycin against Pathogenic Bacteria
Medicinal Chemistry The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism An Integrative Informatics Approach to Explain the Mechanism of Action of N1-(Anthraquinon-2-yl) Amidrazones as BCR/ABL Inhibitors
Current Computer-Aided Drug Design Neuroprotective Gene Therapy for the Treatment of Inherited Retinal Degeneration
Current Gene Therapy New Treatment Approaches in Acute Myeloid Leukemia: Review of Recent Clinical Studies
Reviews on Recent Clinical Trials